# US 2019/0336651 A1 · Patterned electrospun fibers for tissue engineering

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0336651 A1
- Document ID: US20190336651A1
- Status: Published application
- Kind: A1
- Application number: 16/476,874
- Filed: 2018-01-10
- Published: 2019-11-07
- Earliest claimed: 2017-01-10
- Assignees: Ramot at Tel-Aviv University Ltd.
- Applicants: Ramot at Tel-Aviv University Ltd.
- Inventors: Tal DVIR; Sharon FLEISCHER
- Web page: https://patentgrep.com/patent/US20190336651A1

## CPC

- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61K 38/38: Albumins
- A61L 27/227: {Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24}
- A61L 27/3804: {characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}
- A61L 27/3808: {Endothelial cells}
- A61L 27/3826: {Muscle cells, e.g. smooth muscle cells}
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 31/04: Macromolecular materials
- C12N 5/0068: {General culture methods using substrates (for specific animal cell type C12N5/06)}
- A61L 2300/41: Anti-inflammatory agents, e.g. NSAIDs
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61L 2300/414: Growth factors
- A61L 2430/20: for reconstruction of the heart, e.g. heart valves
- C12N 2529/00: Culture process characterised by the use of electromagnetic stimulation
- C12N 2533/50: Proteins
- C12N 2535/00: Supports or coatings for cell culture characterised by topography
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A composition of matter for tissue engineering is disclosed. The composition comprises a plurality of electrospun albumin fibers, wherein an outer surface of the composition comprises a pattern of ridges or indentations, wherein the ridges or indentations are wider than the diameter of a single electrospun albumin fiber of the plurality of electrospun albumin fibers.

## Claims

### Claim 1

A composition of matter for tissue engineering, comprising a plurality of electrospun albumin fibers, wherein an outer surface of the composition comprises a pattern of ridges or indentations, wherein the width of an individual ridge or indentation of said pattern of ridges or indentations is wider than the diameter of a single electrospun albumin fiber of said plurality of electrospun albumin fibers.

### Claim 2 (depends on 1)

The composition of matter of claim 1, wherein the diameter of said plurality of electrospun albumin fibers is less than 10 μm.

### Claim 3 (depends on 1)

The composition of matter of claim 1, being devoid of electrospun synthetic fibers.

### Claim 4 (depends on 1)

The composition of matter of claim 1, wherein said indentations form structures selected from the group consisting of grooves, holes and cages.

### Claim at position 5

5-6. (canceled)

### Claim 7 (depends on 4)

The composition of matter of claim 4, wherein the diameter of said holes and/or the width of the grooves is between 20 μm-500 μm.

### Claim at position 7

8-9. (canceled)

### Claim 10 (depends on 4)

The composition of matter of claim 4, wherein said structures are grooves and cages.

### Claim 11 (depends on 1)

The composition of matter of claim 1, further comprising a cell population seeded on said outer surface.

### Claim 12

(canceled)

### Claim 13 (depends on 11)

The composition of claim 11, wherein said cell population comprises cells selected from the group consisting of cardiomyocytes, endothelial cells, pancreatic beta cells, hepatocytes, skin cells, lung cells and skeletal muscle cells.

### Claim at position 12

14-17. (canceled)

### Claim 18 (depends on 10)

The composition of matter of claim 10, wherein said cages are loaded with particles comprising an agent selected from the group consisting of a growth promoting agent, a neurotransmitter, a differentiating agent, a pro-angiogenic agent, an anti-inflammatory agent and a drug.

### Claim 19 (depends on 1)

A scaffold for tissue engineering comprising at least two layers, wherein each of the layers are fabricated from the composition of matter of claim 1, each layer comprising a pattern with distinct indentations or ridges.

### Claim 20 (depends on 19)

The scaffold of claim 19, wherein at least one of the layers is seeded with cells.

### Claim 21 (depends on 1)

A scaffold for tissue engineering comprising at least two layers, wherein each of the layers are fabricated from the composition of matter of claim 1, each of said at least two layers being seeded with cells of a different cell population.

### Claim 22

(canceled)

### Claim 23 (depends on 21)

The scaffold of claim 21, wherein a first of said at least two layers is seeded with cardiomyocytes and a second of said at least two layers is seeded with endothelial cells.

### Claim 24 (depends on 23)

The scaffold of claim 23, wherein said first layer comprises a pattern of grooves and said second layer comprises a pattern of grooves and cages.

### Claim 25

(canceled)

### Claim 26 (depends on 24)

The scaffold of claim 24, wherein said cages are loaded with particles comprising an agent selected from the group consisting of a growth promoting agent, a differentiating agent, a neurotransmitter, a pro-angiogenic agent, an anti-inflammatory agent and a drug.

### Claim 27 (depends on 21)

The scaffold of any one of claim 21, comprising at least three layers, wherein the third layer is patterned with cages loaded with particles comprising an agent selected from the group consisting of a growth promoting agent, a neurotransmitter, a differentiating agent, a pro-angiogenic agent, an anti-inflammatory agent and a drug.

### Claim 28 (depends on 19)

The scaffold of claim 19, wherein said at least two layers are adhered to one another using a biological glue.

### Claim 29

A method of generating a composition of matter for tissue engineering comprising patterning an outer surface of a composition comprising a plurality of electrospun albumin fibers with indentations or ridges that are wider than the diameter of a single electrospun albumin fiber of said plurality of electrospun albumin fibers, thereby generating the composition of matter.

### Claim at position 25

30-34. (canceled)

### Claim 35 (depends on 20)

A method of culturing cells comprising culturing the scaffold of claim 20 under conditions that allow propagation of the cells, thereby culturing the cells.

### Claim 36 (depends on 11)

A method of culturing cells comprising culturing the composition of matter of claim 11 under conditions that allow propagation of the cells, thereby culturing the cells.
